Isolation-protocol, characterization, and in-vitro performance of equine umbilical vein endothelial cells.

The research article presents an isolation protocol for creating endothelial cells from horse umbilical veins. These cells will be used as a model for understanding blood vessel formation in horses, laying the groundwork for exploring horse-specific vascular operations and treatments.

Introduction

• The article discusses the importance of angiogenesis – the formation of new blood vessels – in various physiological and pathological conditions.
• The research on equine angiogenesis (angiogenesis in horses) is relatively minimal, thus creating a need for appropriate models to study this phenomenon.
• The study highlights the significant use of Human Umbilical Vein Endothelial Cells (HUVECs) in angiogenesis research, advocating for an equivalent model in horses.

Methodology

• The researchers developed an isolation protocol to get endothelial cells from the umbilical veins of horses (EqUVECs).
• They sourced umbilical cords from five foals, collected endothelial cells from them, and confirmed these cells’ identities through morphological and immunohistochemical identification.
• The researchers questioned how well these cells would perform in various assays (tests) often used in angiogenesis research. They also measured the EqUVEC expression of the Vascular Endothelial Growth Factor (VEGF) using ELISA.

Results

• The isolated EqUVECs exhibited endothelial characteristics, forming a homogeneous monolayer with distinctive morphology.
• Immunohistochemical staining confirmed the positive expression of critical endothelial markers such as von Willebrand factor (vWF), CD31, and Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2).
• The performance assessments in the assays showed the viability, proliferation, migration, tube formation, and VEGF-expression capabilities of EqUVECs.

Conclusion

• The research concludes that EqUVECs are an encouraging model for studying equine angiogenesis, providing a foundation for further research into equine-specific vascular processes and therapies.